ELABS — Elliptic Laboratories ASA Balance Sheet
0.000.00%
- NOK1.39bn
- NOK1.33bn
- NOK131.91m
- 60
- 10
- 72
- 42
Annual balance sheet for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | NAS | NAS | NAS | NAS | NAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 98.6 | 217 | 176 | 113 | 74.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18.2 | 46.7 | 47.3 | 67 | 118 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 122 | 265 | 226 | 186 | 195 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.02 | 2.79 | 2.26 | 19.9 | 16.7 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 219 | 371 | 349 | 348 | 361 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.6 | 18.1 | 17.2 | 24.9 | 25 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 30.6 | 28.6 | 23.7 | 42.8 | 35.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Other Equity | |||||
Total Equity | 188 | 343 | 326 | 305 | 325 |
Total Liabilities & Shareholders' Equity | 219 | 371 | 349 | 348 | 361 |
Total Common Shares Outstanding |